Medicaments of insulin, not for retail sale
HS-Code 300331
Supply Chain Analysis
30 entities · 2024 · exports
Source Countries
Trade Value
Total Quantity
Avg per Entity
Top 5 Concentration
Value Distribution (Top 5)
Efficiency Quadrant — Unit Price vs Order Value
Premium · Volume Player · Niche · Weak
United States
$0.01B
73.79% share
European Union
$0.00B
5.13% share
New Zealand
$0.00B
3.73% share
Few dominant players — high dependency risk.
Share Split
Top Exporting Countries
| # | Country | Share | Value | 1Y Growth | 3Y Growth | Signal |
|---|---|---|---|---|---|---|
| 1 | 73.79% | $0.01B | -74.38% | -84.90% | 📉 Sustained Drop | |
| 2 | European Union | 5.13% | $0.00B | +91.20% | -83.99% | 🔄 Recovering |
| 3 | 3.73% | $0.00B | +45.69% | -- | 🚀 Breakout | |
| 4 | Slovak Republic | 3.40% | $0.00B | +242.18% | +348.37% | 🐢 Slowing |
| 5 | 3.10% | $0.00B | +6076.01% | +7.04% | 🚀 Breakout |
Value vs YoY Growth
Bubble size = market share · Right + Up = high value, high growth
Demand Market Analysis
52 entities · 2024 · imports
Buyer Countries
Trade Value
Total Quantity
Avg per Entity
Top 5 Concentration
Value Distribution (Top 5)
Efficiency Quadrant — Unit Price vs Order Value
Premium · Volume Player · Niche · Weak
Algeria
$0.11B
91.23% share
Denmark
$0.00B
3.7% share
Nicaragua
$0.00B
0.97% share
Few dominant players — high dependency risk.
Share Split
Global Trade Map
Exports + Imports by country (hover for details)
Explore more products
Access full trade data across our entire product database.
Have an account? Sign in